Your slide has been added to the download list.

Bimekizumab – Peripheral Arthritis Response in Bio-Naïve & Bio-IR
Category: PsA TreatmentsPsA Treatments

Bimekizumab – Enthesitis Response in Bio-Naïve & Bio-IR
Category: PsA Treatments

Bimekizumab – Dactylitis Response in Bio-Naïve & Bio-IR
Category: PsA Treatments

Bimekizumab – Treatment Response in Non-radiographic Axial Spondyloarthritis
Category: PsA Treatments

Bimekizumab – Treatment Response in Radiographic Axial Spondyloarthritis
Category: PsA Treatments

COMPLETE-PsA – Methotrexate Monotherapy vs. Combination of Methotrexate and Leflunomide
Category: PsA Treatments

ULTRASOUND – Dactylitis: tenosynovitisand subcutaneous tissue inflammation
Category: Imaging

X-Rays – Destruction and new bone formation in PsA
Category: Imaging

X-ray – Similarities and differences between ankylosing spondylitis and psoriatic arthritis in the spine
Category: Imaging

Psoriatic disease is a highly heritable complex genetic disease
Category: Genetics

Heritability estimates of PsV/PsC and PsA vary depending on how it is determined
Category: Genetics

Family history of Psoriasis (PsO) and PsA impacts disease severity, skin and musculoskeletal phenotypes of the proband
Category: Genetics

Genome wide significant loci in PsO (recent variants reaching GWA significance are highlighted in red)
Category: Genetics

Genome wide significant loci in PsA(recent variants reaching GWA significance are highlighted in red)
Category: Genetics

Genes identified in psoriatic disease exhibit low genotype relative risk, so most genes do not provide clinically actionable outcomes
Category: Genetics

HLA associations provide the most robust genetic associations in psoriatic disease
Category: Genetics

HLA-Allele C*06:02 and Disease Expression in Psoriatic Disease
Category: Genetics

Genotype-Phenotype correlations of HLA-B in PsA: HLA-Allele B*27
Category: Genetics

Genotype-Phenotype correlations of HLA-B in PsA: HLA-Allele B*08
Category: Genetics

Most of the disease susceptibility genes identified in psoriatic disease through GWA studies are located outside the MHC region
Category: Genetics

Susceptibility genes identified to date in psoriatic disease can be broadly categorized into several (sometimes overlapping) categories
Category: Genetics

Susceptibility genes and potential pathways (1 of 3)
Category: Genetics

Susceptibility genes and potential pathways (2 of 3)
Category: Genetics

Susceptibility genes and potential pathways (3 of 3)
Category: Genetics

Psoriatic susceptibility genes can also potentially be linked to pathways interrogated by therapeutic agents such as the IL23/IL17 pathway
Category: Genetics

Exome studies have also identified monogenic models of psoriatic disease
Category: Genetics